Barinthus Biotherapeutics plc American Depositary Shares
XNAS:BRNS
0.77
$0.89 - 100.00
$0.76 - 100.00
$0.76
$0.8
$0.8
$0.77
2.92
0.64
20683
157645.8
37885291.26
Chart
TendieTensor AI Analysis
Company
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
Fundamentals
105
-0.420000
0.382450
-0.24
100
BBG00ZZPCP09
BBG00ZZPCPV5
40.72M
40.83M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own BRNS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.